Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThg Regulatory News (THG)

Share Price Information for Thg (THG)

Share Price is delayed by 15 minutes
Get Live Data
33.36    0.36 (1.09%)
Bid:
33.16
Ask:
33.42
Spread: 0.26 (0.784%)
Market Cap: £529.37m
THG Live PriceLast checked at - London Stock Exchange

Intraday Thg Share Chart

Statement regarding share price movement

13 Oct 2021 07:00

RNS Number : 9151O
THG PLC
13 October 2021
 

13 October 2021

 

THG PLC

 

Statement regarding share price movement

 

 

 

THG PLC ("THG or the "Group") notes the fall in the share price yesterday following the Capital Market Event, and confirms that it knows of no notifiable reason for the material share price movement, and that no material new information was disclosed at the event.

 

Since its IPO in September 2020, THG has consistently delivered ahead of its targets set at the time of IPO and recently reported a strong first half performance across all divisions, with Group revenue of £958.8m, +44.7% YoY (CCY). 

 

The Group also has a very strong liquidity position as it enters its peak trading season, with available cash as at 30 September 2021 of £700.0m across long dated 3-5 year facilities. 

 

THG is due to report its Q3 Trading Update on 26 October, and looks forward to updating investors in the ordinary course.

 

 

 

For further information please contact: 

 

Investor enquiries - THG PLC

Kate Grimoldby

Investor.Relations@thg.com

 

Media enquiries:

Powerscourt - Financial PR adviser

Tel: +44 (0) 20 7250 1446

Victoria Palmer-Moore/Nick Dibden/Nick Hayns

thg@powerscourt-group.com

 

THG PLC

Viki Tahmasebi

 

 

 

Viki.tahmasebi@thg.com

ENDS

Notes to editors

THG (www.thg.com) is a vertically integrated, digital-first consumer brands group, retailing its own brands in beauty and nutrition, plus third-party brands, via its proprietary, end-to-end, e-commerce technology, infrastructure and brand-building platform (THG Ingenuity) to an online and global customer base. THG's business is operated through the following businesses:

THG Ingenuity: Ingenuity Commerce provides an end-to-end direct-to-consumer e-commerce solution for consumer brand owners under 'Software as a Service' (SaaS) licences. The wider Ingenuity division provides stand-alone digital services, including hosting, studio content, translation services and beauty product development and manufacturing.

THG Beauty: The globally pre-eminent digital-first brand owner, retailer and manufacturer in the prestige beauty market, combining its prestige portfolio of eight owned brands across skincare, haircare and cosmetics, the provision of a global route to market for over 1,000 third-party beauty brands through its portfolio of websites, including Lookfantastic, Dermstore, Cult Beauty and Mankind and the beauty subscription box brand GLOSSYBOX.

 

THG Nutrition: A group of digital-first Nutrition brands, which includes the world's largest online sports nutrition brand Myprotein, and its family brands (Myvegan, Myvitamins, MP Clothing and Myprotein Pro), with a vertically integrated business model, supported by six THG production facilities.

 

THG OnDemand: Personalisation and customisation is a key offering within THG OnDemand, enabling brands to offer unique products to a vast range of consumers across THG's global territories through websites including Zavvi, IWOOT and Pop in a Box.

Other: Luxury D2C websites including Coggles, AllSole and MyBag, in addition to THG Experience. The latter comprises prestige events locations at Hale Country Club & Spa, King Street Townhouse Hotel and Great John Street Hotel, providing deeply experiential brand building environments, most notably in support of THG Society, the Group's proprietary influencer marketing platform.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SPMGPGCAUUPGUCW
Date   Source Headline
22nd May 20267:00 amRNSNotice of AGM
21st Apr 20267:00 amRNSTrading Statement
20th Apr 20264:45 pmRNSNotice of Q1 Trading Update
8th Apr 20267:00 amRNSAnnual Report & Accounts 2025
26th Mar 20267:00 amRNSPreliminary FY 2025 results
25th Mar 20264:54 pmRNSNotice of Results
24th Feb 20267:45 amRNSPDMR/PCA Shareholding & TR-1 Notification
12th Feb 20267:00 amRNS-RMyprotein licensing partnership with Greencore
2nd Feb 20267:00 amRNSTotal Voting Rights
27th Jan 20263:49 pmRNSTR-1: Notification of major holdings
27th Jan 20263:45 pmRNSTR-1: Notification of Major Holdings
23rd Jan 20262:52 pmRNSTR-1: Notification of Major Holdings
22nd Jan 20263:00 pmRNSApplication for Listing and Total Voting Rights
16th Jan 20267:00 amRNSChange to Board Committee Membership
13th Jan 20267:00 amRNSQ4 2025 Trading Statement
12th Jan 20264:40 pmRNSNotice of Results
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
19th Dec 20252:20 pmRNSTR-1: Notification of Major Holdings
19th Dec 20252:20 pmRNSTR-1: Notification of Major Holdings
16th Dec 20255:50 pmRNSTR-1: Notification of Major Holdings
9th Dec 20254:35 pmRNSTR-1: Notification of Major Holdings
9th Dec 202510:55 amRNSTR-1: Notification of Major Holdings
9th Dec 20259:15 amRNSPDMR/PCA Shareholding & TR-1 Notification
5th Dec 202510:15 amRNSDirector Declaration
5th Dec 202510:05 amRNSAdmission of Convertible Loan Shares and TVR
26th Nov 20259:45 amRNSPDMR/PCA Shareholdings
17th Nov 20257:00 amRNS-RMyprotein joins forces with Mars
3rd Nov 20257:00 amRNSBlock listing Interim Review
28th Oct 202511:14 amRNSDirector Declaration
14th Oct 20257:00 amRNSQ3 2025 Trading Statement
10th Oct 20257:00 amRNSNotice of Trading Update
19th Sep 20256:00 pmRNSOcean Wilsons
11th Sep 20257:00 amRNSInterim results for half-year ended 30 June 2025
10th Sep 20254:45 pmRNSNotice of Interim Results
5th Sep 20257:00 amRNSNotification under UKLR 6.4.9R(2)
6th Aug 20257:42 amRNSDisposal, H1 trading and Nutrition update - Amend
6th Aug 20257:00 amRNSDisposal, H1 trading and Nutrition update
9th Jul 20252:24 pmRNSChanges to Directors’ Responsibilities
25th Jun 20252:38 pmRNSResult of AGM
25th Jun 20257:00 amRNSAGM Trading Statement
5th Jun 20253:56 pmRNSTR-1: Notification of Major Holdings
23rd May 20257:00 amRNSNotice of AGM
1st May 20257:00 amRNSBlock Listing Six Monthly Return
30th Apr 20257:00 amRNSAnnual Report & Accounts 2024
29th Apr 20257:00 amRNSFY 2024 results and Q1 trading statement
23rd Apr 20257:00 amRNSResponse to media speculation
16th Apr 20254:45 pmRNSTR-1: Notification of Major Holdings
4th Apr 202510:30 amRNSTR-1: Notification of Major Holdings
4th Apr 20257:00 amRNSCompletion of debt refinancing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.